IPSEY - Ipsen Skyhawk enter RNA targeting research collab in rare neurological diseases
2024-04-22 02:47:42 ET
More on Ipsen S.A.
- Ipsen And Sutro Partnering On ADCs Is A Deal Offering Opportunities For Investors
- Ipsen secures exclusive global rights of Sutro Biopharma's STRO-003 ADC
- Ipsen gets FDA approval for pancreatic cancer drug regimen
- Historical earnings data for Ipsen S.A.
- Dividend scorecard for Ipsen S.A.